(E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide
TL;DR: (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide (CAS 850159-24-9) is a chemical compound with molecular formula C19H13ClN4O5 and molecular weight 412.06 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-[(E)-(7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylideneamino]-4-nitrobenzamide
Also Known As: (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide, N'-[(E)-(7-chloro-2,3-dihydro[1,4]dioxino[2,3-g]quinolin-8-yl)methylidene]-4-nitrobenzohydrazide, N-[(E)-(7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylideneamino]-4-nitrobenzamide
| Molecular Formula | C19H13ClN4O5 |
|---|---|
| Molecular Weight | 412.06 g/mol |
| LogP | 3.3315 |
| Topological Polar Surface Area | 115.95 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Exact Mass | 412.05743 |
| Heavy Atoms | 29 |
| Complexity | 1147.5398 |
Chemical Identifiers
| CAS Number | 850159-24-9 |
|---|---|
| SMILES | C1COC2=CC3=NC(=C(C=C3C=C2O1)/C=N/NC(=O)C4=CC=C(C=C4)[N+](=O)[O-])Cl |
Product Overview
(E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide (CAS 850159-24-9), with molecular formula C19H13ClN4O5 and molecular weight 412.06 g/mol. IUPAC: N-[(E)-(7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylideneamino]-4-nitrobenzamide.
Chemical Property Profile of (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide
Property Insights of (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide
The XLogP value of 3.3315 indicates that (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 115.95 Ų falls within the moderate polarity range, balancing permeability and solubility for (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide. Following Lipinski's Rule of Five, (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide has 1 hydrogen bond donor(s) and 7 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide?
The CAS number of (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide is 850159-24-9.
What is the molecular formula of (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide?
The molecular formula of (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide is C19H13ClN4O5.
What is the molecular weight of (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide?
The molecular weight of (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide is 412.06 g/mol.
Where can I buy (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide?
You can request a quote for (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide?
Yes, KEHONG BIO provides custom synthesis services for (E)-N'-((7-chloro-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methylene)-4-nitrobenzohydrazide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.